Enhanced CAR-T therapy clears solid tumours by finding ‘faint’ targets

Enhanced CAR-T therapy clears solid tumours by finding ‘faint’ targets
Scientists have developed a highly sensitive receptor that can detect trace amounts of proteins on solid tumours, overcoming a major biological hurdle to using CAR T-cell therapy against such cancers